The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer
Open accessAbstract
Glycogen synthase kinase-3β (GSK-3β) is an evolutionarily conserved serine/threonine kinase, functioning in numerous cellular processes including cell proliferation, DNA repair, cell cycle, signaling and metabolic pathways. GSK-3β is implicated in different diseases including inflammation, neurodegenerative disease, diabetes and cancers. GSK-3β is involved in biological processes of tumorigenesis, therefore, it is rational that GSK-3β inhibitors were employed to target malignant tumors. The effects of GSK-3β inhibitors in combination of radiation and chemotherapeutic drugs have been reported in various types of cancers, suggesting GSK-3β would play important roles in cancer treatments. GSK-3β is involved in multiple signal pathway including Wnt/β-catenin, PI3K/PTEN/AKT and Notch. GSK-3β also functions in DNA repair through phosphorylation of DNA repair factors and affecting their binding to chromatin. This review focuses on the molecular mechanism of GSK-3β in DNA repair, special in base excision repair and double-strands break repair, the roles of GSK-3β in inhibition of apoptosis through activation of NF-κB, and the effects of GSK-3β inhibitors on radio- and chemosensitization of various types of cancers. This article is part of a Special Issue entitled: GSK-3 and related kinases in cancer, neurological and other disorders edited by James McCubrey, Agnieszka Gizak and Dariusz Rakus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Yost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,165
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Mechanism and regulation of human non-homologous DNA end-joining
Lieber, M. R., Ma, Y., Pannicke, U., & Schwarz, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1202 · Cited by 973
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Repair of Strand Breaks by Homologous Recombination
Jasin, M., & Rothstein, R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012740 · Cited by 887
EMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Repair and Genetic Consequences of Endogenous DNA Base Damage in Mammalian Cells
Barnes, D. E., & Lindahl, T. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.092448 · Cited by 753
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
Sørensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuåsen, R. G., Lundin, C., Bartek, J., & Helleday, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1212 · Cited by 666
DNA Repair in Mammalian Cells: Base excision repair: the long and short of it
Robertson, A. B., Klungland, A., Rognes, T., & Leiros, I. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8736-z · Cited by 651
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
Jope, R. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00206-2 · Cited by 500
Zhao, H., Watkins, J. L., & Piwnica-Worms, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557299 · Cited by 461
Glycogen synthase kinase 3: a drug target for CNS therapies
Bhat, R. V., Budd Haeberlein, S. L., & Avila, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02422.x · Cited by 408
Glycogen synthase kinase 3: A key regulator of cellular fate
Forde, J. E., & Dale, T. C. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7045-7 · Cited by 385
Cross, D. A. E., Culbert, A. A., Chalmers, K. A., Facci, L., Skaper, S. D., & Reith, A. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00251.x · Cited by 377
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333
Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis
Bijur, G. N., De Sarno, P., & Jope, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7583 · Cited by 301
Rylatt, D. B., Aitken, A., Bilham, T., Condon, G. D., Embi, N., & Cohen, P. (1980) · PubMed · Cited by 285
Ye, L.-Y., Chen, W., Bai, X.-L., Xu, X.-Y., Zhang, Q., Xia, X.-F., Sun, X., Li, G.-G., Hu, Q.-D., Fu, Q.-H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0977 · Cited by 275
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage
Watcharasit, P., Bijur, G. N., Zmijewski, J. W., Song, L., Zmijewska, A., Chen, X., Johnson, G. V. W., & Jope, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122062299 · Cited by 266
VEGF-Mediated Angiogenesis Links EMT-Induced Cancer Stemness to Tumor Initiation
Fantozzi, A., Gruber, D. C., Pisarsky, L., Heck, C., Kunita, A., Yilmaz, M., Meyer-Schaller, N., Cornille, K., Hopfer, U., Bentires-Alj, M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1641 · Cited by 232
RYLATT, D. B., AITKEN, A., BILHAM, T., CONDON, G. D., EMBI, N., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06060.x · Cited by 206
Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription
Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205
Harada, Y., Sakai, M., Kurabayashi, N., Hirota, T., & Fukada, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506225200 · Cited by 200
Role of 53BP1 in the Regulation of DNA Double-Strand Break Repair Pathway Choice
Gupta, A. K. D., Hunt, C. R., Chakraborty, S., PANDITA, R. K., Yordy, J. S., Ramnarain, D. B., Horikoshi, N., & Pandita, T. K. (2013) · Radiation Research · doi:10.1667/rr13572.1 · Cited by 180
King, T. D., Bijur, G. N., & Jope, R. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03005-0 · Cited by 177
Vanillins--a novel family of DNA-PK inhibitors
Durant, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg753 · Cited by 174
Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal Transitions
Doble, B. W., & Woodgett, J. R. (2007) · Cells Tissues Organs · doi:10.1159/000101306 · Cited by 170
Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining
Boeckman, H. J., Trego, K. S., & Turchi, J. J. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0032 · Cited by 170
Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193
Adachi, N., Suzuki, H., Iiizumi, S., & Koyama, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306500200 · Cited by 169
Kang, T., Wei, Y., Honaker, Y., Yamaguchi, H., Appella, E., Hung, M.-C., & Piwnica-Worms, H. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.002 · Cited by 164
Vijay, G. V., Zhao, N., Den Hollander, P., Toneff, M. J., Joseph, R., Pietila, M., Taube, J. H., Sarkar, T. R., Ramirez-Pena, E., Werden, S. J., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1125-0 · Cited by 163
Russo, M. T., De Luca, G., Degan, P., Parlanti, E., Dogliotti, E., Barnes, D. E., Lindahl, T., Yang, H., Miller, J. H., & Bignami, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0355 · Cited by 160
Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer
Walz, A., Ugolkov, A., Chandra, S., Kozikowski, A., Carneiro, B. A., O'Halloran, T. V., Giles, F. J., Billadeau, D. D., & Mazar, A. P. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2240 · Cited by 160
The cancer stem-cell signaling network and resistance to therapy
Carnero, A., Garcia‐Mayea, Y., Mir, C., Lorente, J., Rubio, I. T., & LLeonart, M. E. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.07.001 · Cited by 159
Fitzgerald, T. L., Lertpiriyapong, K., Cocco, L., Martelli, A. M., Libra, M., Candido, S., Montalto, G., Cervello, M., Steelman, L. S., Abrams, S. L., et al. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.06.003 · Cited by 144
Pettersen, H. S., Visnes, T., Vågbø, C. B., Svaasand, E. K., Doseth, B., Slupphaug, G., Kavli, B., & Krokan, H. E. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr563 · Cited by 143
Targeting DNA repair mechanisms in cancer
Furgason, J. M., & Bahassi, E. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.009 · Cited by 136
Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53
Charvet, C., Wissler, M., Brauns‐Schubert, P., Wang, S.-J., Tang, Y., Sigloch, F. C., Mellert, H. S., Brandenburg, M., Lindner, S. E., Breit, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.033 · Cited by 132
Wang, H., Wang, H., Powell, S. N., Iliakis, G., & Wang, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1289 · Cited by 130
GSK-3β controls NF-kappaB activity via IKKγ/NEMO
Medunjanin, S., Schleithoff, L.-M., Fiegehenn, C., Weinert, S., Zuschratter, W., & Braun-Dullaeus, R. C. (2016) · Scientific Reports · doi:10.1038/srep38553 · Cited by 119
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
McCubrey, J. A., Fitzgerald, T. L., Yang, L. V., Lertpiriyapong, K., Steelman, L. S., Abrams, S. L., Montalto, G., Cervello, M., Neri, L. M., Cocco, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13991 · Cited by 116
Ryves, W. J., Dajani, R. B., Pearl, L. H., & Harwood, A. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6305 · Cited by 114
Loss of Nonhomologous End Joining Confers Camptothecin Resistance in DT40 Cells
Adachi, N., So, S., & Koyama, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313910200 · Cited by 108
Kozikowski, A. P., Gaisina, I. N., Petukhov, P. A., Sridhar, J., King, L. T., Blond, S. Y., Duka, T., Rusnak, M., & Sidhu, A. (2006) · ChemMedChem · doi:10.1002/cmdc.200500039 · Cited by 107
Grassilli, E., Narloch, R., Federzoni, E. A., Ianzano, L., Pisano, F., Giovannoni, R., Romano, G., Masiero, L., Leone, B. E., Bonin, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3289 · Cited by 99
An expanding GSK3 network: implications for aging research
Souder, D. C., & Anderson, R. M. (2019) · GeroScience · doi:10.1007/s11357-019-00085-z · Cited by 98
DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer.
Kashishian, A., Douangpanya, H., Clark, D., Schlachter, S. T., Eary, C. T., Schiro, J. G., Huang, H., Burgess, L. E., Kesicki, E. A., & Halbrook, J. (2003) · PubMed · Cited by 95
Namba, T., Kodama, R., Moritomo, S., Hoshino, T., & Mizushima, T. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.172 · Cited by 86
GSK-3 inhibition overcomes chemoresistance in human breast cancer
Ugolkov, A. V., Gaisina, I. N., Zhang, J., Billadeau, D. D., White, K. P., Kozikowski, A. P., Jain, S., Cristofanilli, M., Giles, F. J., O’Halloran, T. V., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.006 · Cited by 84
Wang, X., Khadpe, J. D., Hu, B., Iliakis, G. E., & Wang, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301876200 · Cited by 82
Kitano, A., Shimasaki, T., Chikano, Y., Nakada, M., Hirose, M., Higashi, T., Ishigaki, Y., Endo, Y., Takino, T., Sato, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055289 · Cited by 79
Zhao, S., & Sancar, A. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb03214.x · Cited by 78
Pyko, I. V., Nakada, M., Sabit, H., Teng, L., Furuyama, N., Hayashi, Y., Kawakami, K., Minamoto, T., Fedulau, A., & Hamada, J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt182 · Cited by 76
Ding, L., Madamsetty, V. S., Kiers, S., Alekhina, O., Ugolkov, A. V., Dube, J., Zhang, Y., Zhang, J., Wang, E., Dutta, S. K., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0799 · Cited by 74
Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer
Gao, C., Yuan, X., Jiang, Z., Gan, D., Ding, L., Sun, Y., Zhou, J., Xu, L., Liu, Y., & Wang, G. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05239-3 · Cited by 72
Skarková, V., Králová, V., Vítovcová, B., & Rudolf, E. (2019) · Cells · doi:10.3390/cells8030234 · Cited by 64
The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin
Zhang, Y., Qu, D., Morris, E. J., O’Hare, M. J., Callaghan, S. M., Slack, R. S., Geller, H. M., & Park, D. S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2593-06.2006 · Cited by 62
Taylor, A., & Rudd, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01653 · Cited by 61
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
Shimasaki, T., Ishigaki, Y., Nakamura, Y., Takata, T., Nakaya, N., Nakajima, H., Sato, I., Zhao, X., Kitano, A., Kawakami, K., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0484-9 · Cited by 60
McGrail, D. J., Mezencev, R., Kieu, Q. M. N., McDonald, J. F., & Dawson, M. (2014) · The FASEB Journal · doi:10.1096/fj.14-257345 · Cited by 60
Eom, T. Y., Roth, K. A., & Jope, R. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702973200 · Cited by 59
Adachi, N., Iiizumi, S., So, S., & Koyama, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.099 · Cited by 59
Matsumoto, T., Yokoi, A., Hashimura, M., Oguri, Y., Akiya, M., & Saegusa, M. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22816 · Cited by 59
Cai, G., Wang, J., Xin, X., Ke, Z., & Luo, J. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.657 · Cited by 58
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
Tian, T., Mingyi, M., Qiu, X., & Qiu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12861 · Cited by 56
Sengupta, S., Katz, S. C., Sengupta, S., & Sampath, P. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.035 · Cited by 55
Fhit and CHK1 Have Opposing Effects on Homologous Recombination Repair
Hu, B., Wang, H., Wang, X., Lu, H., Huang, C.-F., Powell, S. N., Huebner, K., & Wang, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1966 · Cited by 54
Kim, S.-H., Song, Y., & Seo, H. R. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1050-1 · Cited by 54
Huehls, A. M., Huntoon, C. J., Joshi, P. M., Baehr, C., Wagner, J. M., Wang, X., Lee, M. Y., & Karnitz, L. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.100164 · Cited by 53
GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
Watson, R. L., Spalding, A. C., Zielske, S. P., Morgan, M. A., Kim, A. C., Bommer, G. T., Eldar-Finkelman, H., Giordano, T. J., Fearon, E. R., Hammer, G. D., et al. (2010) · Neoplasia · doi:10.1593/neo.92112 · Cited by 51
Thornton, T. M., Delgado, P., Chen, L., Salas, B., Krementsov, D. N., Fernández, M., Vernia, S., Davis, R. J., Heimann, R., Teuscher, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms10553 · Cited by 48
Wang, R., Yu, Z., Chen, F., Xu, H., Shen, S., Chen, W., Chen, L., Su, Q., Zhang, L., Bi, J., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.005 · Cited by 48
Kawazoe, H., Bilim, V. N., Ugolkov, A. V., Yuuki, K., Naito, S., Nagaoka, A., Kato, T., & Tomita, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.147 · Cited by 46
Yao, F., Xiong, Y., Shen, X., Zhao, Y., Zhu, Y., Wang, L., & Liang, Z. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.01.012 · Cited by 44
Ito, H., Ichiyanagi, O., Naito, S., Bilim, V. N., Tomita, Y., Kato, T., Nagaoka, A., & Tsuchiya, N. (2016) · BMC Cancer · doi:10.1186/s12885-016-2418-7 · Cited by 43
Fu, Y., Hu, D., Qiu, J. G., Xie, X., Ye, F., & Lü, W. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31820d7366 · Cited by 39
The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions
Weng, Y., Chien, T., Kuan, I., & Chern, Y. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0473-x · Cited by 37
GSK-3 Represses Growth Factor-inducible Genes by Inhibiting NF-κB in Quiescent Cells
Graham, J. R., Tullai, J. W., & Cooper, G. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053785 · Cited by 35
Nuclear GSK3β induces DNA double-strand break repair by phosphorylating 53BP1 in glioblastoma
Yang, Y., Lei, T., Du, S., Tong, R., Wang, H., Yang, J., Huang, J., Sun, M., Wang, Y., & Dong, Z. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4237 · Cited by 35
Zhang, K., Song, H., Yang, P., Dai, X., Li, Y., Wang, L., Du, J., Pan, K., & Zhang, T. (2015) · Cell Proliferation · doi:10.1111/cpr.12161 · Cited by 34
GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
Ren, J.-L., Liu, T., Han, Y., Wang, Q., Chen, Y., Li, G., & Jiang, L. (2018) · Diagnostic Pathology · doi:10.1186/s13000-018-0708-x · Cited by 33
Zhang, J., Zhao, Y., Lv, Y.-P., Cheng, P., Chen, W., Duan, M., Teng, Y., Wang, T., Peng, L., Mao, F.-Y., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1412900 · Cited by 32
Yun, S., Yoon, H., & Chung, Y. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0348-4 · Cited by 29
Xie, K., Ye, Y., Zeng, Y., Gu, J. H., Yang, H., & Wu, X. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx079 · Cited by 20
Yu, C.-Y., Chang, W.-C., Zheng, J.-H., Hung, W.-H., & Cho, E.-C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.137 · Cited by 19
Li, Y., Yuan, F., Wu, T., Lü, L., Liu, J., Feng, W., & Chen, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.07.002 · Cited by 18
Baehr, C., Huntoon, C. J., Hoang, S.-M., Jerde, C. R., & Karnitz, L. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746081 · Cited by 17
Henrich, S. M., Usadel, C., Werwein, E., Burdová, K., Janščák, P., Ferrari, S. M., Heß, D., & Klempnauer, K. (2017) · Scientific Reports · doi:10.1038/srep41663 · Cited by 17
GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells
Wu, Y., Hsieh, C.-T., Chiu, Y., Chou, S.-C., Kao, J., Shieh, D.-C., & Lee, Y.-J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208094 · Cited by 15
Yeste‐Velasco, M., Folch, J., Jiménez, A., Rimbau, V., Pallàs, M., & Camins, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.019 · Cited by 13
Tsai, I.-T., Kuo, C., Liou, J., & Chang, J. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0432-6 · Cited by 11
Cited by
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
CCL5/CCR5 axis in human diseases and related treatments
Zeng, Z., Lan, T., Wei, Y., & Wei, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.004 · Cited by 378
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Duda, P., Akula, S. M., Abrams, S. L., Steelman, L. S., Martelli, A. M., Cocco, L., Ratti, S., Candido, S., Libra, M., Montalto, G., et al. (2020) · Cells · doi:10.3390/cells9051110 · Cited by 284
The role of PI3K signaling pathway in Alzheimer’s disease
Pan, J., Yao, Q., Wang, Y., Chang, S., Li, C., Wu, Y., Shen, J., & Yang, R. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1459025 · Cited by 89
Self-citation
Metadata
- Authors
- Lin, J., Song, T., Li, C., & Mao, W.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 1867
- Issue
- 5
- Pages
- 118659
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W3002292920
- Cited by
- 268
- References
- 103
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.